| Dialysis Bundle Changes ESA, IV Iron Use - Renal Business Today |
|
|
Renal Business Today Nephrologists have reported changes in the use of erythropoietin stimulating agents (ESAs) and intravenous (IV) iron in the management of renal anemia in dialysis patients due to the new dialysis bundled payment system, according to a new report from |